Our data showed that the expression of Spred2 was down-regulated significantly in CML CD34+ cells, and Spred2 over-expression could restore the ability of erythroid differentiation. The gene discussed is SPRED2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.